China's first AI-BCI medical standard

China has established the world's first national product standard for AI-powered brain-computer interface (BCI) medical devices, regulating the collection, processing, and storage of neural data. This regulatory framework ensures the consistency and quality of brainwave data, which is essential for training AI algorithms to accurately interpret patient intentions for clinical applications like restoring motor function or vision. By setting clear benchmarks, the standard addresses industry fragmentation and improves patient safety. Beyond technical requirements, the discussion highlights critical ethical challenges, particularly the lack of guaranteed long-term support for patients who develop functional dependency on experimental devices after clinical trials conclude. While the U.S. and EU maintain general AI medical device guidelines, China’s specific focus on BCI data sets represents a significant milestone that could influence future international standardization, potentially facilitating more seamless cross-border medical management for BCI users.